Search

Search Results
Results 8331 - 8340 of 8356 for allergy
  • Zinforo
    Drug - 10 Feb 2021
    Consumer Medicine Information (CMI) about Zinforo intended for persons living in Australia.
  • Loette (New Formulation)
    Drug - 16 Nov 2020
    Consumer Medicine Information (CMI) about Loette (New Formulation) (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.
  • Ebixa
    Drug - 10 Jun 2020
    Consumer Medicine Information (CMI) about Ebixa (Memantine hydrochloride) intended for persons living in Australia.
  • Norinyl-1
    Drug - 16 Mar 2020
    Consumer Medicine Information (CMI) about Norinyl-1 (Mestranol and Norethisterone) intended for persons living in Australia.
  • Lamisil Tablets
    Drug - 13 Feb 2020
    Consumer Medicine Information (CMI) about Lamisil Tablets (terbinafine) intended for persons living in Australia.
  • Adefin XL
    Drug - 14 Jan 2020
    Consumer Medicine Information (CMI) about Adefin XL (nifedipine) intended for persons living in Australia.
  • Triasyn
    Drug - 20 Dec 2019
    Consumer Medicine Information (CMI) about Triasyn (Ramipril and felodipine e-pril fell-odd-ip-een)) intended for persons living in Australia.
  • Loette
    Drug - 13 Dec 2019
    Consumer Medicine Information (CMI) about Loette (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.
  • Nordette
    Drug - 12 Dec 2019
    Consumer Medicine Information (CMI) about Nordette (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.
  • Monofeme
    Drug - 12 Dec 2019
    Consumer Medicine Information (CMI) about Monofeme (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback